✦ LIBER ✦

PCA2: IRINOTECAN IN FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER: IMPROVED SURVIVAL AND COST EFFECTIVENESS COMPARED WITH INFUSIONAL 5-FLUOROURACIL

✍ Scribed by DL Jackson; A Burrell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan in second-line treatment of m

✍ T.J. Iveson; T. Hickish; C. Schmitt; E. Van Cutsem 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Cost-effectiveness projections of oxalip

✍ Bruce E. Hillner; Deborah Schrag; Daniel J. Sargent; Charles S. Fuchs; Richard M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

PCN70 MODELLING THE COST EFFECTIVENESS O

✍ C Holmberg; R Aultman; U Siebert; E Sabate; M Gyldmark 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Cost-effectiveness analysis of irinoteca

✍ Warren Mark Hart; Carlos Rubio-Terrés; Linda Pronk; Svetlana Kobina; Eduardo Día 📂 Article 📅 2003 🏛 Springer Milan 🌐 Spanish ⚖ 188 KB

Differences in Efficacy and Safety Betwe

✍ Francesco Montagnani; Antonella Chiriatti; Sara Licitra; Camillo Aliberti; Giamm 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 122 KB

664 PUBLICATION Cetuximab in combination

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB